The abstract is read at the publisher; the summary is JClub's.
Oral trans-resveratrol after alkali burn in female Wistar rats reduces epithelial defect area in a dose-dependent way, with day-10 defect area dropping to 0.31% at 300 mg/kg/day.
- Why it matters: Corneal alkali injury impairs epithelial repair and promotes opacity and neovascularization, and the study addresses whether systemic resveratrol dosing can improve these outcomes.
- What they did: Rats received vehicle or oral trans-resveratrol at 100, 200, or 300 mg/kg/day for 42 days, and masked image analysis quantified epithelial defects through day 10 and opacity and neovascularization through day 42.
- The result: The epithelial defect area showed a significant group-by-time interaction (Greenhouse-Geisser-corrected F[7.00, 56.00] = 5.93, P < 0.001), and at day 42 the 300 mg/kg/day group had lower opacity and neovascularization areas by -19.86 and -20.56 percentage points (both P < 0.001).
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.